A major discovery in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in several kinds of malignancies, leading https://bookmarkinginfo.com/story21898092/mini-antibodies-reactivate-the-p53-protein-new-new-pathway-for-cancer-management